Authors: Nguyen, CL McClay, EF Cole, DJ O'Brien, PH Gillanders, WE Metcalf, JS Maize, JC Baron, PL

Citation: Cl. Nguyen et al., Melanoma thickness and histology predict sentinel lymph node status, AM J SURG, 181(1), 2001, pp. 8-11

Authors: de las Alas, MM Christen, RD Gately, DP Weiner, DE Benbatoul, K Kirmani, S D'Agostino, HR Plaxe, SC Darrah, D McClay, EF Aebi, S Howell, SB Los, G

Citation: Mm. De Las Alas et al., Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel, CANC CHEMOT, 45(5), 2000, pp. 381-388

Authors: McClay, EF McClay, MET Monroe, L Baron, PL Cole, DJ O'Brien, PH Metcalf, JS Maize, JC

Citation: Ef. Mcclay et al., The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma, BR J CANC, 83(1), 2000, pp. 16-21

Authors: McClay, EF Jones, JA

Citation: Ef. Mcclay et Ja. Jones, Characterization of a human melanoma cell line with non-oestrogen receptordependent tamoxifen resistance, MELANOMA RE, 9(6), 1999, pp. 531-537

Authors: Aebi, S Schnider, TW Los, G Heath, DD Darrah, D Kirmani, S McClay, EF D'Agostino, H Plaxe, SC Fink, D De las Alas, MM Howell, SB Christen, RD

Citation: S. Aebi et al., A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel, CANC CHEMOT, 44(3), 1999, pp. 259-265